查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1918284

全球白色生物技術市場－2026-2031年預測

Global White Biotech Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球白色生物技術市場預計將從 2025 年的 3,347.55 億美元成長到 2031 年的 5,410.97 億美元，複合年成長率為 8.33%。

白色生物技術市場是一個涵蓋工業生物技術的領域，其特點是利用微生物、植物細胞和酵素等活細胞來創造永續的產品和製程。該領域被視為現代生物經濟的基礎，為生質燃料、生質塑膠、藥品、精細化學品和工業酶等多個工業領域提供環境友善替代方案，以取代傳統的石油化工生產方式。

推動市場擴張的關鍵因素是全球減少碳排放和降低環境影響的迫切需求。隨著各產業和政府加強應對氣候變化，白色生物技術為脫碳提供了一條重要途徑。與傳統製造方法相比，該製程通常能耗更低、產生的廢棄物更少，並且生產可生物分解的最終產品。這種與永續性目標的根本契合，使得生物基解決方案作為石化燃料衍生材料的可行替代方案，需求強勁，從而使白色生物技術成為工業轉型的關鍵技術。

同時，強而有力的政府支持和策略性政策舉措正在加速全球市場發展。各國政府和區域政府日益認知到培育強大的生物經濟的戰略重要性。透過直接投資、研究津貼和支持性法規結構，公共正積極促進創新風險規避和生物基製造能力的擴張。這種自上而下的支持對於建立必要的基礎設施和刺激整個價值鏈上的私人投資至關重要。

基因工程和製程最佳化領域的持續創新推動了技術進步，為該領域的發展奠定了基礎。精準改造微生物以提高其效率、產量和新型化合物的生產能力是關鍵驅動力。基因工程的進步，以及發酵技術和生物催化劑設計的改進，不斷擴展白色生物技術的應用範圍和商業性可行性。這些創新降低了生產成本，並使生產更複雜、高附加價值的產品成為可能。

從區域角度來看，亞太市場正崛起為一個主導性的高成長區域。這一成長軌跡得益於龐大且不斷成長的人口、快速的工業化以及政府積極推行的永續政策。該地區各國正在實施旨在提升國內生物技術能力、減少對進口化石燃料的依賴以及應對緊迫環境挑戰的各項措施。該地區大規模的製造業基礎以及對循環經濟原則日益成長的重視，為工業生物技術解決方案的採納和推廣提供了沃土。

白色生物技術在多個戰略產業的廣泛應用，充分證明了其經濟重要性和韌性。白色生物技術的應用範圍並不局限於單一領域，而是在能源（生質燃料）、材料（生質塑膠）、健康（藥品和酵素）以及農業等領域的變革中發揮著至關重要的作用。這種多樣性降低了風險，並確保成長能夠順應跨產業永續性和供應鏈安全的趨勢。該技術在開發現有產品的兼容替代品和全新材料方面的作用，鞏固了其作為多功能工業平台的地位。

總之，白色生物技術市場的發展受到環境需求、政策支持和科學創新三者強強聯合的驅動。全球對減少碳排放的迫切關注構成了強勁的長期需求驅動力，而政府的生物經濟戰略也為其發展注入了關鍵動力。基因工程和製程工程的持續進步正在拓展技術和商業性可行性領域。亞太地區憑藉其龐大的人口和經濟規模，可望實現顯著成長。白色生物技術市場策略性地位於工業生產力和生態學永續性的交匯點，預計將繼續融入全球製造業格局。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
  • 可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

企業使用我們的報告的目的是什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊）及主要發展動態。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球白色生物技術市場（依微生物類型分類）

  • 介紹
  • 酵母菌
  • 細菌
  • 其他

6. 全球白色生物技術市場（按應用分類）

  • 介紹
  • 生質燃料
  • 生質塑膠
  • 生化產品
  • 其他

7. 全球白色生物技術市場（以最終用戶分類）

  • 介紹
  • 化學品
  • 食品/飲料
  • 電力和能源
  • 其他

8. 全球白色生物技術市場（按地區分類）

  • 介紹
  • 北美洲
    • 依微生物類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依微生物類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依微生物類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依微生物類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依微生物類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Cargill Incorporated
  • DuPont
  • DSM-Firmenich
  • BASF SE
  • Evonik Industries AG
  • Laurus Labs
  • Corbion NV
  • Novonesis
  • ADM
  • Lonza Group Ltd

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616284

Global White Biotech Market, with a 8.33% CAGR, is forecasted to grow from USD 334.755 billion in 2025 to USD 541.097 billion in 2031.

The white biotechnology market, encompassing industrial biotechnology, is defined by the application of living cells-such as microorganisms, plant cells, and enzymes-to create sustainable products and processes. This sector stands as a cornerstone of the modern bioeconomy, offering environmentally favorable alternatives to conventional petrochemical-based production across a diverse range of industries including biofuels, bioplastics, pharmaceuticals, fine chemicals, and industrial enzymes.

A paramount driver for market expansion is the global imperative to reduce carbon emissions and environmental impact. As industries and governments intensify efforts to mitigate climate change, white biotech provides a critical pathway for decarbonization. Its processes typically consume less energy, generate reduced waste, and yield biodegradable end-products compared to traditional manufacturing. This fundamental alignment with sustainability goals is creating robust demand for bio-based solutions as viable replacements for fossil fuel-derived materials, positioning white biotech as an essential technology for industrial transformation.

Concurrently, significant governmental support and strategic policy initiatives are accelerating market development worldwide. National and regional governments are increasingly recognizing the strategic importance of fostering a strong bioeconomy. Through direct investments, research grants, and supportive regulatory frameworks, public policy is actively de-risking innovation and scaling up bio-based manufacturing capacities. This top-down support is crucial for building the necessary infrastructure and stimulating private sector investment across the value chain.

Technological advancement forms the bedrock of the sector's progress, with continuous innovation in genetic engineering and process optimization. The ability to precisely modify microorganisms-enhancing their efficiency, yield, and ability to produce novel compounds-is a key enabler. Advances in genetic modification techniques, alongside improvements in fermentation technology and biocatalyst design, are continually expanding the commercial feasibility and scope of white biotech applications. These innovations are lowering production costs and enabling the manufacture of more complex, high-value products.

From a regional perspective, the Asia Pacific market is emerging as a dominant and high-growth area. This trajectory is fueled by a combination of large, expanding populations, rapid industrialization, and proactive government policies aimed at promoting sustainable development. Nations within the region are implementing initiatives to build domestic biotech capabilities, reduce reliance on imported fossil resources, and address pressing environmental challenges. The region's substantial manufacturing base and growing focus on circular economy principles provide a fertile ground for the adoption and scaling of industrial biotechnology solutions.

The market's broad application across multiple strategic industries underscores its economic significance and resilience. White biotech is not confined to a single sector but is integral to transformative shifts in energy (biofuels), materials (bioplastics), health (pharmaceuticals and enzymes), and agriculture. This diversification mitigates risk and ensures that growth is fueled by cross-industrial trends toward sustainability and supply chain security. The technology's role in creating drop-in replacements as well as entirely novel materials solidifies its position as a versatile industrial platform.

In conclusion, the white biotechnology market is being propelled by a powerful convergence of environmental necessity, policy support, and scientific innovation. The urgent global focus on reducing carbon footprints provides a compelling, long-term demand driver, while governmental bioeconomy strategies are providing essential momentum. Continuous advancements in genetic and process engineering are expanding the technical and commercial horizons of what is possible. With the Asia Pacific region poised for substantial growth due to its demographic and economic scale, the white biotech market is strategically positioned at the intersection of industrial productivity and ecological sustainability, poised for continued integration into the global manufacturing landscape.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

White Biotech Market Segmentation

  • By Microorganism Type
  • Yeast
  • Bacteria
  • Others
  • By Application
  • Biofuels
  • Bioplastic
  • Biochemicals
  • Others
  • By End-User
  • Chemicals
  • Food & Beverage
  • Power & Energy
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WHITE BIOTECH MARKET BY MICROGRANISM TYPE

  • 5.1. Introduction
  • 5.2. Yeast
  • 5.3. Bacteria
  • 5.4. Others

6. WHITE BIOTECH MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Biofuels
  • 6.3. Bioplastic
  • 6.4. Biochemicals
  • 6.5. Others

7. WHITE BIOTECH MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Chemicals
  • 7.3. Food & Beverage
  • 7.4. Power & Energy
  • 7.5. Others

8. WHITE BIOTECH MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Microorganism Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Microorganism Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Microorganism Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Microorganism Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Microorganism Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Cargill Incorporated
  • 10.2. DuPont
  • 10.3. DSM-Firmenich
  • 10.4. BASF SE
  • 10.5. Evonik Industries AG
  • 10.6. Laurus Labs
  • 10.7. Corbion NV
  • 10.8. Novonesis
  • 10.9. ADM
  • 10.10. Lonza Group Ltd

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations